Mercer to Acquire AltamarCAM Asset Management Firm
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 19 2026
0mins
Should l Buy MRSH?
Mercer, a business of Marsh, has agreed to acquire AltamarCAM, a specialist private markets asset manager and solutions provider with EUR 20B in assets under management. After closing, AltamarCAM will become an integral part of Mercer's wider private markets business. The transaction is subject to customary closing conditions, including regulatory filings, and is expected to close in the second half of 2026. As of next year, the combined businesses will go to market under the Marsh brand.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy MRSH?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on MRSH
Wall Street analysts forecast MRSH stock price to rise
0 Analyst Rating
0 Buy
0 Hold
0 Sell
Current: 169.170
Low
Averages
High
Current: 169.170
Low
Averages
High
About MRSH
Marsh & McLennan Companies, Inc. is a professional services company in the areas of risk, strategy and people. The Company conducts business through two segments: Risk and Insurance Services, and Consulting. Risk and Insurance Services segment includes risk management activities (risk advice, risk transfer and risk control and mitigation solutions) as well as insurance and reinsurance broking and services. It conducts business in this segment through Marsh and Guy Carpenter. Marsh is an insurance broker and risk advisor, serving companies, institutions and individuals. Guy Carpenter is a reinsurance intermediary and advisor. Consulting segment includes health, wealth and career advice, solutions and products, and specialized management, strategic, economic and brand consulting services. It conducts business in this segment through Mercer and Oliver Wyman Group. Oliver Wyman Group serves as a critical strategic, economic and brand advisor to private sector and governmental clients.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Marsh to Announce Q1 Financial Results on April 16, 2026
- Earnings Release Schedule: Marsh is set to announce its Q1 financial results on April 16, 2026, before market open, ensuring timely access to critical information for investors through a news release.
- Investor Teleconference: Following the release, President and CEO John Doyle and CFO Mark McGivney will lead a teleconference at 8:30 a.m. EDT, discussing financial results and engaging in a Q&A session to enhance transparency and investor interaction.
- Webcast Availability: The teleconference will be accessible via a live audio webcast on the company's website, with a replay available approximately two hours post-event, ensuring that investors who cannot attend live can still access the information.
- Company Background: Marsh is a global leader in risk, reinsurance, and capital management consulting, boasting annual revenues of $27 billion and over 95,000 employees, serving clients in 130 countries, which underscores its significant influence and market position in the industry.
See More
Marsh's Acquisition of AltamarCAM Boosts Stock Price
- Stock Price Recovery: Marsh (MRSH) shares rose 3.3% in the last trading session to close at $176.48, with notable trading volume exceeding typical levels, despite a 4.5% decline over the past four weeks.
- Asset Acquisition Value: Marsh's Mercer unit agreed to acquire AltamarCAM, adding €20 billion in assets under management, positioning Madrid as a key hub and strengthening its presence in Europe and Latin America.
- Positive Earnings Outlook: The upcoming quarterly earnings report is expected to show an EPS of $3.22, reflecting a year-over-year increase of 5.2%, with revenues projected at $7.39 billion, up 4.6%, indicating strong future growth potential.
- Earnings Estimate Revision: Despite positive earnings expectations, the consensus EPS estimate has been revised 0.7% lower over the last 30 days, which typically does not correlate with stock price appreciation, necessitating close monitoring of MRSH's future performance.
See More
Oliver Wyman Appoints Helen Leis as Global Head of Leadership and Change
- New Role Creation: Oliver Wyman has appointed Helen Leis as Global Head of Leadership and Change, a position aimed at guiding clients through uncertainty and complex transformations, highlighting the firm's strategic focus on leadership and change management.
- Leadership and Change Management: In her new role, Leis will continue as Co-Head of M&A Americas, leveraging her 30 years of industry experience to help clients develop pragmatic strategies and tools to navigate rapidly changing market conditions.
- Addressing Complex Challenges: Oliver Wyman's Leadership and Change initiatives will assist organizations in building the necessary operating models and leadership skills to adapt to shifts in technology, economic conditions, and workforce expectations, thereby turning disruption into opportunity.
- Strategic Importance: CEO Nick Studer emphasized that this role is crucial for advancing the firm's long-term efforts to embed transformative leadership and change management capabilities, aiming to enhance organizational collaboration and impact to ensure greater business success in complex environments.
See More
Marsh & McLennan Acquires AltamarCAM, Expanding Private Markets Reach
- Acquisition Announcement: Marsh & McLennan has announced the acquisition of Spain-based private markets asset manager AltamarCAM, which manages €20 billion in assets, thereby enhancing Marsh's expertise in private markets and increasing its competitive edge.
- Transaction Details: Although the financial terms of the deal were not disclosed, the transaction is expected to close in the second half of 2026, indicating Marsh's long-term strategic planning for expanding its asset management business.
- Market Impact: This acquisition will enable Marsh's Mercer unit to gain AltamarCAM's expertise and client base, thereby driving growth potential in the private markets and further solidifying its position in the global asset management industry.
- Future Outlook: By integrating AltamarCAM's resources, Marsh & McLennan anticipates being able to offer more comprehensive investment solutions to meet the growing client demand and achieve sustainable growth in a competitive market.
See More
Mercer Acquires AltamarCAM to Expand Private Markets
- Acquisition Overview: Mercer has agreed to acquire AltamarCAM, a specialist private markets asset manager with €20 billion in assets under management, significantly enhancing Mercer's capabilities in the private markets sector.
- Platform Expansion: The integration of AltamarCAM will add expertise in secondaries, co-investments, bespoke accounts, and evergreen vehicles, enabling Mercer to offer comprehensive multi-asset private market solutions to clients and further solidifying its market leadership.
- Strategic Hub Establishment: With AltamarCAM headquartered in Madrid, the acquisition will transform it into a strategic hub within Mercer's global private markets platform, leveraging the deep expertise and investment talent from both firms to enhance overall service capabilities.
- Future Outlook: The transaction is expected to close in the second half of 2026, with the combined businesses operating under the Marsh brand, marking Mercer's ongoing expansion and innovation in the global private markets arena.
See More
Global Healthcare Spending to Double to $23.1 Trillion by 2040
- Surge in Healthcare Spending: Global healthcare spending is projected to rise from $11.8 trillion in 2025 to $23.1 trillion by 2040, driven by factors such as aging populations, labor shortages, and systemic inefficiencies, placing unprecedented strain on healthcare systems.
- Potential for Efficiency Gains: Despite rapid increases in spending, productivity in healthcare has remained flat; however, the adoption of AI, automation, and robotics could offset up to 60% of projected cost increases if implemented in a coordinated manner with strong support.
- Cost Savings Pathways: Depending on the adoption scenario, the healthcare system could achieve annual net savings of $1.1 trillion (4% cost reduction) by 2040, escalating to $5.1 trillion (22% reduction) under a breakthrough adoption scenario, highlighting the significant potential of technology integration.
- Critical Enablers for Adoption: The report identifies five key enablers for rapid technology adoption, including investment in technology infrastructure, stronger talent pipelines, reforms to reimbursement and liability frameworks, modernized innovation-friendly regulations, and a shift from labor-centric to technology-enabled models to achieve lasting system-wide impact.
See More
Marsh to Announce Q1 Financial Results on April 16, 2026
- Earnings Release Schedule: Marsh is set to announce its Q1 financial results on April 16, 2026, before market open, ensuring timely access to critical information for investors through a news release.
- Investor Teleconference: Following the release, President and CEO John Doyle and CFO Mark McGivney will lead a teleconference at 8:30 a.m. EDT, discussing financial results and engaging in a Q&A session to enhance transparency and investor interaction.
- Webcast Availability: The teleconference will be accessible via a live audio webcast on the company's website, with a replay available approximately two hours post-event, ensuring that investors who cannot attend live can still access the information.
- Company Background: Marsh is a global leader in risk, reinsurance, and capital management consulting, boasting annual revenues of $27 billion and over 95,000 employees, serving clients in 130 countries, which underscores its significant influence and market position in the industry.
See More
Marsh's Acquisition of AltamarCAM Boosts Stock Price
- Stock Price Recovery: Marsh (MRSH) shares rose 3.3% in the last trading session to close at $176.48, with notable trading volume exceeding typical levels, despite a 4.5% decline over the past four weeks.
- Asset Acquisition Value: Marsh's Mercer unit agreed to acquire AltamarCAM, adding €20 billion in assets under management, positioning Madrid as a key hub and strengthening its presence in Europe and Latin America.
- Positive Earnings Outlook: The upcoming quarterly earnings report is expected to show an EPS of $3.22, reflecting a year-over-year increase of 5.2%, with revenues projected at $7.39 billion, up 4.6%, indicating strong future growth potential.
- Earnings Estimate Revision: Despite positive earnings expectations, the consensus EPS estimate has been revised 0.7% lower over the last 30 days, which typically does not correlate with stock price appreciation, necessitating close monitoring of MRSH's future performance.
See More
Oliver Wyman Appoints Helen Leis as Global Head of Leadership and Change
- New Role Creation: Oliver Wyman has appointed Helen Leis as Global Head of Leadership and Change, a position aimed at guiding clients through uncertainty and complex transformations, highlighting the firm's strategic focus on leadership and change management.
- Leadership and Change Management: In her new role, Leis will continue as Co-Head of M&A Americas, leveraging her 30 years of industry experience to help clients develop pragmatic strategies and tools to navigate rapidly changing market conditions.
- Addressing Complex Challenges: Oliver Wyman's Leadership and Change initiatives will assist organizations in building the necessary operating models and leadership skills to adapt to shifts in technology, economic conditions, and workforce expectations, thereby turning disruption into opportunity.
- Strategic Importance: CEO Nick Studer emphasized that this role is crucial for advancing the firm's long-term efforts to embed transformative leadership and change management capabilities, aiming to enhance organizational collaboration and impact to ensure greater business success in complex environments.
See More
Marsh & McLennan Acquires AltamarCAM, Expanding Private Markets Reach
- Acquisition Announcement: Marsh & McLennan has announced the acquisition of Spain-based private markets asset manager AltamarCAM, which manages €20 billion in assets, thereby enhancing Marsh's expertise in private markets and increasing its competitive edge.
- Transaction Details: Although the financial terms of the deal were not disclosed, the transaction is expected to close in the second half of 2026, indicating Marsh's long-term strategic planning for expanding its asset management business.
- Market Impact: This acquisition will enable Marsh's Mercer unit to gain AltamarCAM's expertise and client base, thereby driving growth potential in the private markets and further solidifying its position in the global asset management industry.
- Future Outlook: By integrating AltamarCAM's resources, Marsh & McLennan anticipates being able to offer more comprehensive investment solutions to meet the growing client demand and achieve sustainable growth in a competitive market.
See More
Mercer Acquires AltamarCAM to Expand Private Markets
- Acquisition Overview: Mercer has agreed to acquire AltamarCAM, a specialist private markets asset manager with €20 billion in assets under management, significantly enhancing Mercer's capabilities in the private markets sector.
- Platform Expansion: The integration of AltamarCAM will add expertise in secondaries, co-investments, bespoke accounts, and evergreen vehicles, enabling Mercer to offer comprehensive multi-asset private market solutions to clients and further solidifying its market leadership.
- Strategic Hub Establishment: With AltamarCAM headquartered in Madrid, the acquisition will transform it into a strategic hub within Mercer's global private markets platform, leveraging the deep expertise and investment talent from both firms to enhance overall service capabilities.
- Future Outlook: The transaction is expected to close in the second half of 2026, with the combined businesses operating under the Marsh brand, marking Mercer's ongoing expansion and innovation in the global private markets arena.
See More
Global Healthcare Spending to Double to $23.1 Trillion by 2040
- Surge in Healthcare Spending: Global healthcare spending is projected to rise from $11.8 trillion in 2025 to $23.1 trillion by 2040, driven by factors such as aging populations, labor shortages, and systemic inefficiencies, placing unprecedented strain on healthcare systems.
- Potential for Efficiency Gains: Despite rapid increases in spending, productivity in healthcare has remained flat; however, the adoption of AI, automation, and robotics could offset up to 60% of projected cost increases if implemented in a coordinated manner with strong support.
- Cost Savings Pathways: Depending on the adoption scenario, the healthcare system could achieve annual net savings of $1.1 trillion (4% cost reduction) by 2040, escalating to $5.1 trillion (22% reduction) under a breakthrough adoption scenario, highlighting the significant potential of technology integration.
- Critical Enablers for Adoption: The report identifies five key enablers for rapid technology adoption, including investment in technology infrastructure, stronger talent pipelines, reforms to reimbursement and liability frameworks, modernized innovation-friendly regulations, and a shift from labor-centric to technology-enabled models to achieve lasting system-wide impact.
See More
